Skip to main content

letter

. 1976 Feb;3(1):199–201. doi: 10.1111/j.1365-2125.1976.tb00592.x

Prazosin in normal subjects: plasma levels, blood pressure and heart rate.

A J Wood, P Bolli, F O Simpson

PMCID: PMC1428805 PMID: 973941

199

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Bolli P., Simpson F. O. A preliminary clinical trial of Prazosin: a new oral antihypertensive agent. N Z Med J. 1974 May 22;79(516):969–972. [PubMed] [Google Scholar]
Cohen B. M. Prazosin hydrochloride (CP-12,299-1), an oral anti-hypertensive agent: preliminary clinical observations in ambulatory patients. J Clin Pharmacol J New Drugs. 1970 Nov-Dec;10(6):408–417. [PubMed] [Google Scholar]
Gabriel R., Meek D., Ghosh B. C. Letter: Collapse after prazosin hydrochloride. Lancet. 1975 May 10;1(7915):1095–1095. doi: 10.1016/s0140-6736(75)91873-5. [DOI] [PubMed] [Google Scholar]
Kincaid-Smith P., Fang P., Laver M. C. A new look at the treatment of severe hypertension. Clin Sci Mol Med Suppl. 1973 Aug;45 (Suppl 1):75s–787. doi: 10.1042/cs045075s. [DOI] [PubMed] [Google Scholar]
Stokes G. S., Weber M. A. Prazosin: preliminary report and comparative studies with other antihypertensive agents. Br Med J. 1974 May 11;2(5914):298–300. doi: 10.1136/bmj.2.5914.298. [DOI] [PMC free article] [PubMed] [Google Scholar]
Wood A. J., Phelan E. L., Simpson F. O. Cardiovascular effects of prazosin in normotensive and genetically hypertensive rats. Clin Exp Pharmacol Physiol. 1975 Jul-Aug;2(4):297–304. doi: 10.1111/j.1440-1681.1975.tb01836.x. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES